Lyell Competitors and Similar CompaniesClear all

Lyell's competitors and similar companies include NovoCure.

	Lyell Lyell Immunopharma is a T-cell reprogramming company to cure patients with solid tumors.	NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
Founding Date	Founding Date 2018	Founding Date 2000
Type	Type Public	Type Public
Tags	Tags Healthcare biotech oncology platform therapy	Tags Healthcare biotech medical devices oncology platform therapy
Locations	Locations South San Francisco, US HQ Bothell, US Seattle, US	Locations Saint Helier, JE HQ München, DE Haifa, IL Tokyo, JP Root, CH Malvern, US New York, US see more
Employees	Employees 188	Employees 1,488
Valuation ($)	Valuation ($) 243.3 m	Valuation ($) 1.8 b
Financial
Revenue (est.)	Revenue (est.) $36k (FY, 2025)	Revenue (est.) $655.4m (FY, 2025)
Net income	Net income ($274.4m) (FY, 2025)	Net income ($136.2m) (FY, 2025)

For sources of this data, please see the company profile

Saint Helier, JE

Employees

1,488

NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.

Financial